- Advantest’s full-year operating income forecast is 242.00 billion yen, which is below the estimate of 292.8 billion yen.
- The company expects a net income of 179.00 billion yen, falling short of the estimated 222.2 billion yen.
- Projected net sales are 755.00 billion yen, whereas the estimate was higher at 860.36 billion yen.
- In the fourth quarter, Advantest’s operating income surged to 64.04 billion yen, compared to 19.53 billion yen in the previous year, but still below the estimate of 69.22 billion yen.
- Fourth quarter net income was 39.97 billion yen, a significant rise from 15.15 billion yen year-over-year, but less than the expected 54.5 billion yen.
- Net sales for the fourth quarter reached 232.35 billion yen, a 71% increase year-over-year, surpassing the estimate of 203.06 billion yen.
- Current market sentiment includes 15 buy ratings, 7 hold ratings, and 0 sell ratings.
A look at Advantest Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Advantest Corp has a positive long-term outlook. With strong scores in Growth and Resilience, the company is positioned well for future expansion and is deemed to have the ability to withstand economic challenges. This indicates that Advantest Corp is focused on growing its business and has solid fundamentals to support its operations.
Although Advantest Corp scores lower in Value, Dividend, and Momentum, the elevated scores in Growth and Resilience outweigh these factors. The company’s core business of producing semiconductor testing devices and electronic measuring instruments aligns with the technological advancements in the industry, presenting opportunities for sustained growth and stability in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
